Coronary Artery Disease in Systemic Lupus Erythematosus: What Do the Facts Say?

Area of Science:

• Rheumatology
• Cardiology
• Immunology

Background:

• Systemic lupus erythematosus (SLE) is a chronic autoimmune disease disproportionately affecting women of reproductive age.
• SLE patients face a substantially increased risk of cardiovascular events, with coronary artery disease contributing to a significant portion of mortality.
• Cardiovascular disease risk in SLE is multifactorial, influenced by traditional risk factors and disease-specific elements.

Purpose of the Study:

• To review the pathogenesis and clinical manifestations of cardiovascular disease in SLE.
• To explore the interplay of traditional and SLE-specific risk factors in cardiovascular disease development.
• To discuss current research on biomarkers and therapeutic strategies for cardiovascular risk management in SLE patients.

Main Methods:

• Literature review of studies on SLE and cardiovascular disease.
• Analysis of epidemiological data on cardiovascular risk in SLE populations.
• Synthesis of information on pathogenic mechanisms, including accelerated atherosclerosis.

Main Results:

• Accelerated atherosclerosis is a key contributor to cardiovascular morbidity and mortality in SLE.
• Disease activity, autoantibodies, organ damage, and treatment regimens are significant SLE-specific risk factors.
• Cardiovascular manifestations in SLE range from angina to myocardial infarction and sudden death.

Conclusions:

• Cardiovascular disease poses a major threat to patients with SLE, necessitating comprehensive risk assessment.
• Identifying and managing both traditional and SLE-specific risk factors is crucial for improving cardiovascular prognosis.
• Further research into biomarkers and novel treatments is essential to mitigate cardiovascular complications in SLE.